Creon 20 Minimicrospheres
Natural health product licensed in Canada
- Licence holder
- Abbott Laboratories Co.
- NPN or DIN-HM
- 02239008
- Status
- Inactive licence
- Licence date
- 23 December 2009
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hypromellosephthalate, Titanium dioxide, E 171, Light mineral oil, Gélatine, Oxide de fer jaune, E 172, Dimethicone 1000, Dibutyl phthalate, Macrogol 4000, Oxyde de fer rouge, E 172
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adults (Cystic Fibrosis Patients) | Not specified | 500 LU/kg | Not specified |
| Children (Cystic Fibrosis Patients) | minimum: 4 years | 500 LU/kg | Not specified |
| Children (Cystic Fibrosis Patients) | maximum: 4 years | 1,000 LU/kg | Not specified |
| Adults (Conditions Associated with Exocrine Pancreatic Insufficiency) | Not specified | minimum: 12,500 LU ; maximum: 40,000 LU | Not specified |
| Adults (Conditions Associated with Exocrine Pancreatic Insufficiency) | Not specified | minimum: 25,000 LU ; maximum: 80,000 LU | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
For replacement therapy where digestion is not adequate due to pancreatic exocrine insufficiency as in cystic fibrosis, chronic pancreatitis, steatorrhea, post pancreatectomy, post gastrointestinal bypass surgery (e.g. gastroenterostomy) and ductal obstruction from neoplasm.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 02239008
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.